Previous Close | 17.01 |
Open | 17.36 |
Bid | 16.80 x 2200 |
Ask | 20.55 x 1800 |
Day's Range | 17.23 - 18.42 |
52 Week Range | 5.51 - 25.41 |
Volume | |
Avg. Volume | 2,696,377 |
Market Cap | 2.899B |
Beta (5Y Monthly) | 3.54 |
PE Ratio (TTM) | 4.96 |
EPS (TTM) | 3.60 |
Earnings Date | Mar 07, 2022 - Mar 11, 2022 |
Forward Dividend & Yield | 0.09 (0.49%) |
Ex-Dividend Date | Jun 29, 2022 |
1y Target Est | 25.78 |
The mean of analysts' price targets for Vermilion (VET) points to a 26.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Does Vermilion Energy (VET) have what it takes to be a top stock pick for momentum investors? Let's find out.
The major indexes are showing slight gains on the day with an hour left of trading. Mirati Therapeutics is up sharply today on early positive test news for its lung cancer treatment. The Nasdaq composite, which started the day lower and climbed early in the session, was trending sideways the past few hours with a 0.